The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

topazpharma.com

Stage

Acquired | Acquired

Total Raised

$20.5M

About Topaz Pharmaceuticals

Topaz Pharmaceuticals is a pharmaceutical company dedicated to the health and well being of children. Topz is also developing a treatment for head lice.On February 3, 2012, Topaz Pharmaceuticals was acquired by Sanofi Pasteur. The terms of the transaction were not disclosed.

Topaz Pharmaceuticals Headquarter Location

100 Witmer Road Suite 280

Horsham, Pennsylvania, 19044,

United States

267-960-3330

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Topaz Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Topaz Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Topaz Pharmaceuticals News

FDA Approves Sanofi’s Treatment for Head Lice

Feb 9, 2012

Known as Sklice, the treatment had been acquired by Sanofi from Topaz Pharmaceuticals last year. The company claimed that the Sklice lotion can kill off the parasites within 10 minutes of applying it on the head. Clinical trials have shown Sklice to get rid of lice in more than three fourths of the kids who took part in the studies. Less than 1 percent of the kids who took part in the studies displayed any side effects which ranged from eye irritation, dandruff, dry skin, burning sensation and redness in the eye. Source: Medindia P Bread and Dinner Rolls Have High Salt Levels: CDC Fathers Pass on Heart Disease Risk to Sons Via Genetic Variation on the Y Chromosome M Post your Comments Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site. * Your comment can be maximum of 2500 characters Notify me when reply is posted I agree to the terms and conditions Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished. Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading. Share

  • Where is Topaz Pharmaceuticals's headquarters?

    Topaz Pharmaceuticals's headquarters is located at 100 Witmer Road, Horsham.

  • What is Topaz Pharmaceuticals's latest funding round?

    Topaz Pharmaceuticals's latest funding round is Acquired.

  • How much did Topaz Pharmaceuticals raise?

    Topaz Pharmaceuticals raised a total of $20.5M.

  • Who are the investors of Topaz Pharmaceuticals?

    Investors of Topaz Pharmaceuticals include Sanofi Pasteur, Aisling Capital, F-Prime Capital, Ben Franklin Technology Partners of Southeastern PA and Fidelity Investments.

  • Who are Topaz Pharmaceuticals's competitors?

    Competitors of Topaz Pharmaceuticals include Aquinox Pharmaceuticals, Provepep, Conatus Pharmaceuticals, MAP Pharmaceuticals, Micromet and 11 more.

You May Also Like

E
Ectopharma

EctoPharma is a company developing therapeutic pesticides for specific healthcare and veterinary markets, for conditions such as the treatment of human head lice.

I
IVREA Pharmaceuticals

IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.

C
Catena Pharmaceuticals

Catena Pharmaceuticals is focused on the development and commercialization of GPCR antagonists, particularly in the areas of cancer and fibrotic disease. Catena's chemistry is capable of affecting a specific class of GPCRs known to be relevant in a variety of disease states.

H
Humanetics Corporation

Humanetics Corporation is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and wellbeing in markets with urgent and unmet needs with a focus on radiation modulators for oncology, medical imaging and medical countermeasure uses.

A
Anza Therapeutics

Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabolically Active (KBMA) Listeria platforms which can be engineered to express antigens specific to the disease being treated.

P
P2D Biosciences

P2D, Inc. is a pharmaceutical company focused on developing new pharmaceuticals for brain disorders

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.